Phase III Study of Compound Formula Realgar-Indigo Naturalis Plus Imatinib Versus Placebo Plus Imatinib in Adult CML-CP Patients With Ph+

This study is enrolling participants by invitation only.
Sponsor:
Information provided by (Responsible Party):
Junmin Li, Ruijin Hospital
ClinicalTrials.gov Identifier:
NCT01755325
First received: December 18, 2012
Last updated: August 20, 2014
Last verified: August 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)